Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S28 & S29 7/14/03 7/28/03 | Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-025 8/26/02 8/30/02 8/26/02 | Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-023 11/26/01 4/28/03 | Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-019 8/8/01 4/28/03 | Xalatan (latanoprost) ophthalmic solution, 0.005%, Pharmacia & Upjohn Company NDA 20-597/S-010 | Latanoprost Ophthalmic Solution, Par Pharma, Tentative Approval | Latanoprost Ophthalmic Solution, Apotex, Inc., Tentative Approval | Xalatan (latanoprost) Ophthalmic Solution, Pharmacia and Upjohn Company, Labeling Revision | Latanoprost Ophthalmic Solution, Alcon Research, Ltd., Tentative Approval | Latanoprost Ophthalmic Solution, Bausch and Lomb, Inc., Tentative Approval | Latanoprost Ophthalmic Solution, PharmaForce, Inc., Tentative Approval | Latanoprost Ophthalmic Solution, Alcon Research, Ltd., Approval | Latanoprost Ophthalmic Solution, Apotex Inc., Approval | Latanoprost Ophthalmic Solution, Bausch and Lomb, Inc., Approval | Latanoprost Ophthalmic Solution, Mylan Pharmaceuticals Inc., Approval | Latanoprost Ophthalmic Solution, PharmaForce, Inc., Approval | Latanoprost Ophthalmic Solution, Paddock Laboratories, Inc., Approval | Xalatan, latanoprost, Solution/Drops; Ophthalmic, Pharmacia and Upjohn, Labeling Revision | Xalatan, latanoprost, Solution/Drops; Ophthalmic, Pharmacia and Upjohn, Manufacturing Change or Addition ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2013 Betterchem.com